Texas Oncology Foundation Inc
Income Statement
Fiscal Year Start:
Jan 1
Data visualization unavailable
Revenues in 2024
$2,112,896
Contributions
N/A
Fundraising Events
N/A
Investments
N/A
Government Grants
N/A
Program Services
N/A
Membership Dues
N/A
Expenses in 2024
$1,246,175
Grants
43%
Salaries & Benefits
29%
Other
11%
Fees to Service Providers
10%
Offices, Occupancy & IT
5%
Advertising & Promotion
<1%
Depreciation
<1%
Benefits to Members
0%
Interest
0%
Revenues
2023
2024
Change
Contributions
$1,205,944
$1,890,966
+57%
Government Grants
$0
$0
-
Fundraising Events
$103,575
$370,242
+257%
Program Services
$0
$0
-
Membership Dues
$0
$0
-
Investments
$52,612
$57,041
+8%
Other
-$108,113
-$205,353
+90%
Total Revenues
$1,254,018
$2,112,896
+68%
Expenses
2023
2024
Change
Grants
$418,580
$536,045
+28%
Benefits to Members
$0
$0
-
Salaries & Benefits
$386,075
$367,008
-5%
Fees to Service Providers
$94,894
$125,998
+33%
Advertising & Promotion
$7,750
$11,955
+54%
Offices, Occupancy & IT
$41,883
$67,819
+62%
Interest
$375
$0
-100%
Depreciation
$1,926
$2,167
+13%
Other
$80,643
$135,183
+68%
Total Expenses
$1,032,126
$1,246,175
+21%
Net income
2023
2024
Change
Net income
+$221,892
+$866,721
+291%
Functional Expenses
Summary
2023
2024
Change
Program
$690,416
$905,347
+31%
Admin
$248,740
$203,617
-18%
Fundraising
$92,970
$137,211
+48%
Total Expenses
$1,032,126
$1,246,175
+21%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)